Implication of the deacetylase sirtuin-1 on synovial angiogenesis and persistence of experimental arthritis
- 7 May 2020
- journal article
- research article
- Published by BMJ in Annals Of The Rheumatic Diseases
- Vol. 79 (7), 891-900
- https://doi.org/10.1136/annrheumdis-2020-217377
Abstract
Objectives To decipher the phenotype of endothelial cells (ECs) derived from circulating progenitors issued from patients with rheumatoid arthritis (RA). Methods RA and control ECs were compared according to their proliferative capacities, apoptotic profile, response to tumour necrosis factor (TNF)-α stimulation and angiogenic properties. Microarray experiments were performed to identify gene candidates relevant to pathological angiogenesis. Identified candidates were detected by RT-PCR and western blot analysis in ECs and by immunohistochemistry in the synovium. Their functional relevance was then evaluated in vitro after gene invalidation by small interfering RNA and adenoviral gene overexpression, and in vivo in the mouse model of methyl-bovine serum albumin-(mBSA)-induced arthritis. Results RA ECs displayed higher proliferation rate, greater sensitisation to TNF-α and enhanced in vitro and in vivo angiogenic capacities. Microarray analyses identified the NAD-dependent protein deacetylase sirtuin-1 (SIRT1) as a relevant gene candidate. Decreased SIRT1 expression was detected in RA ECs and synovial vessels. Deficient endothelial SIRT1 expression promoted a proliferative, proapoptotic and activated state of ECs through the acetylation of p53 and p65, and lead the development of proangiogenic capacities through the upregulation of the matricellular protein cysteine-rich angiogenic protein-61. Conditional deletion of SIRT1 in ECs delayed the resolution of experimental methyl-bovine serum albumin-(mBSA)-induced arthritis. Conversely, SIRT1 activation reversed the pathological phenotype of RA ECs and alleviates signs of experimental mBSA-induced arthritis. Conclusions These results support a role of SIRT1 in RA and may have therapeutic implications, since targeting angiogenesis, and especially SIRT1, might be used as a complementary therapeutic approach in RA.Keywords
Funding Information
- Arthritis R&D
- Société Française de Rhûmatologie
- Pfizer (Bourse Passerelle)
This publication has 44 references indexed in Scilit:
- The ways and means that fine tune Sirt1 activityTrends in Biochemical Sciences, 2013
- Simvastatin inhibits cysteine‐rich protein 61 expression in rheumatoid arthritis synovial fibroblasts through the regulation of sirtuin‐1/FoxO3a signalingArthritis & Rheumatism, 2012
- The impact of acetylation and deacetylation on the p53 pathwayProtein & Cell, 2011
- Resveratrol induces apoptosis MH7A human rheumatoid arthritis synovial cells in a sirtuin 1-dependent mannerRheumatology International, 2010
- Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activityArthritis Research & Therapy, 2010
- MicroRNA 217 Modulates Endothelial Cell Senescence via Silent Information Regulator 1Circulation, 2009
- SirT1 Is an Inhibitor of Proliferation and Tumor Formation in Colon CancerOnline Journal of Public Health Informatics, 2009
- Sirt1 increases skeletal muscle precursor cell proliferationEuropean Journal of Cell Biology, 2009
- Mortality in rheumatoid arthritis patientsAnnals Of The Rheumatic Diseases, 1999
- The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritisArthritis & Rheumatism, 1988